MNTS.NASDAQMomentus INC

8-K: Momentus Secures $1.5M Private Placement, $50M Equity Line

Sentiment:

Capital Raise


Momentus Inc. announced a private placement of a junior secured convertible note and warrants, raising $1.5 million, alongside a new $50 million equity purchase agreement.

Delay expectedThe company is required to file a registration statement for the resale of shares under the Equity Purchase Agreement by October 25, 2025, and use best efforts to have it declared effective by November 24, 2025. Failure to meet these deadlines could result in liquidated damages.The company must hold a stockholder meeting within 60 days of September 25, 2025, to approve share issuances exceeding 19.9% of outstanding shares. Failure to obtain this approval or delays in doing so could impact the full utilization of the financing agreements.
Capital raiseA private placement offering resulted in $1,500,000 in gross proceeds through the sale of a Junior Secured Convertible Note ($1,630,435 principal amount) and Investor Warrants.AIR Warrants were issued, allowing the investor to purchase up to an additional $4,000,000 in principal amount of Convertible Notes and Investor Warrants.An Equity Purchase Agreement provides the company with the right, but not the obligation, to sell up to $50,000,000 in Common Stock to the investor at $1.24 per share.A commitment fee of $750,000, payable in cash or pre-funded warrants, was part of the Equity Purchase Agreement.

Summary

  • Momentus Inc. entered into a private placement offering with Yield Point NY, LLC on September 25, 2025, raising approximately $1,500,000 in gross proceeds.
  • The private placement included a Junior Secured Convertible Note with an aggregate principal amount of $1,630,435, an 8% original issue discount, and a conversion price of $1.116 per share, maturing in September 2026.
  • Warrants to purchase up to 1,460,964 shares of Class A common stock at an exercise price of $1.40 per share were also issued, exercisable immediately for five years.
  • Additionally, AIR Warrants were sold, allowing the investor to purchase up to $4,000,000 in principal amount of additional Convertible Notes and Investor Warrants over five years.
  • A separate Equity Purchase Agreement was signed on September 25, 2025, granting Momentus the right, but not the obligation, to sell up to $50,000,000 in Common Stock to Yield Point NY, LLC.
  • The purchase price for shares under the Equity Purchase Agreement is $1.24 per share.
  • As a commitment fee for the Equity Purchase Agreement, Momentus will either pay $750,000 in cash or issue pre-funded warrants to purchase common stock with a value of $750,000 (exercise price $0.00001 per share).
  • Momentus is obligated to hold a stockholder meeting within 60 days to approve the issuance of shares exceeding 19.9% of shares outstanding, as per Nasdaq rules.
  • The company will file a registration statement on Form S-3 for the resale of the private placement securities within 30 days and for the equity purchase agreement shares by October 25, 2025.

Sentiment

Score: 5

Explanation: The capital raise provides necessary funding and flexibility, which is positive for operations. However, the terms involve significant potential dilution and junior secured debt, which could be viewed negatively by investors. The need for shareholder approval for a substantial portion of the equity line also introduces uncertainty.

Positives

  • Secured $1.5 million in immediate gross proceeds from the private placement, providing working capital.
  • Established a flexible equity line of credit for up to $50 million, offering a significant potential source of future capital.
  • The commitment fee for the equity line is either cash or pre-funded warrants, offering financial flexibility to the company.
  • The AIR Warrants provide an option for additional capital raises up to $4 million in notes and warrants, further enhancing funding potential.

Negatives

  • The convertible note carries an 8% original issue discount, reducing immediate cash inflow relative to the principal amount.
  • The convertible note is junior secured, indicating a lower priority in case of default compared to existing senior debt.
  • The conversion price of $1.116 and warrant exercise price of $1.40 could lead to significant dilution for existing shareholders if the stock price is lower or if a large number of shares are issued.
  • The equity line of credit's purchase price of $1.24 per share could be dilutive depending on the prevailing market price.
  • The company is restricted from entering into other equity lines of credit or variable rate transactions (with some exceptions) for a period, potentially limiting future financing options.
  • Shareholder approval is required for issuances exceeding 19.9% of outstanding shares, which introduces a potential hurdle and delay.

Risks

  • Dilution Risk: The issuance of convertible notes, warrants, and shares under the equity purchase agreement could lead to substantial dilution for existing shareholders.
  • Market Price Volatility: The effectiveness and attractiveness of the equity line of credit are dependent on the company's stock price, as the purchase price is fixed at $1.24 per share.
  • Regulatory Compliance: Failure to obtain shareholder approval for share issuances exceeding Nasdaq's 19.9% cap could limit the company's ability to fully utilize the financing agreements.
  • Liquidation Damages: Failure to meet registration statement deadlines or maintain effectiveness could result in the company paying liquidated damages to the investor.
  • Subordination of Debt: The Junior Secured Convertible Note is subordinate to Senior Secured Debt, increasing risk for the noteholder in a default scenario.
  • Covenant Breaches: Breaching negative covenants in the convertible note (e.g., incurring prohibited indebtedness, making cash dividends) could trigger an Event of Default.
  • Public Information Failure: Failure to satisfy Rule 144(c) public information requirements could lead to liquidated damages.
  • Listing Default: Failure to maintain listing on a Trading Market could result in liquidated damages.

Future Outlook

The company aims to use the proceeds from these financing agreements for general corporate purposes and working capital, which may include debt repayment. It plans to maintain its Nasdaq listing and comply with all reporting requirements. The equity line provides a flexible funding mechanism for future needs, subject to market conditions and shareholder approval.

Management Comments

  • Momentus Inc. entered into a securities purchase agreement with Yield Point NY, LLC, pursuant to which the Company agreed to sell a Junior Secured Convertible Note and warrants.
  • The Company received approximately $1,500,000 in gross proceeds from the Offering.
  • Under the Equity Purchase Agreement, the Company has the right, but not the obligation, to direct the Investor to purchase up to $50,000,000 in shares of Common Stock.
  • The Company will use the net proceeds from the offering of Put Shares for general corporate purposes.

Industry Context

na

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Shareholder Approval RequirementCompany agreed to hold a stockholder meeting within 60 days to solicit affirmative vote for approval of issuance in excess of 19.9% of shares outstanding as of the Purchase Agreement date, in accordance with Nasdaq rules.2025-09-25This is a standard governance requirement for significant dilutive transactions, ensuring shareholder oversight. Failure to obtain approval could limit the company's ability to fully utilize the financing.
Negative Covenants on Convertible NoteThe Convertible Note contains negative covenants prohibiting certain actions like incurring additional indebtedness (beyond Permitted Indebtedness), creating new liens (beyond Permitted Liens), amending organizational documents (except for reverse stock splits for Nasdaq compliance), declaring cash dividends, or engaging in certain related party transactions without consent.2025-09-25These covenants restrict management's flexibility in financial and strategic decisions to protect the noteholder's interest.
Restriction on Equity Line of Credit/Variable Rate TransactionsFor as long as the Notes remain outstanding, the Company agreed not to effect or enter into an Equity Line of Credit or agreement to effect any issuance involving a variable rate transaction, other than an at-the-market offering of Common Stock.2025-09-25Limits future financing options to protect the terms of the current convertible note, potentially reducing flexibility for future capital needs.
Restriction on Other Equity Lines (Equity Purchase Agreement)For a period ending on the earlier of 12 months after the Effective Date of the Registration Statement or the termination of the Equity Purchase Agreement, the Company will not enter into any other equity line of credit agreement without the Investor's prior written consent.2025-09-25Further restricts the company's ability to seek alternative equity financing arrangements, concentrating reliance on the current investor for a specified period.

Stakeholder Impact

  • Shareholders: Potential for significant dilution from the conversion of notes and exercise of warrants, as well as the equity line of credit. Shareholder approval is required for substantial issuances.
  • Creditors: The new convertible note is junior secured, meaning it ranks below existing senior secured debt in a liquidation scenario.
  • Company (Management/Operations): Provides immediate capital and a flexible funding mechanism for working capital and general corporate purposes, but imposes covenants that restrict certain financial and strategic actions.
  • Investor (Yield Point NY, LLC): Gains a convertible debt instrument with interest and equity upside potential, plus a flexible equity purchase right, and a commitment fee.

Next Steps

  • File a Current Report on Form 8-K with the SEC on the Closing Date.
  • File a registration statement on Form S-3 for the resale of private placement securities within 30 days of September 25, 2025.
  • Cause the private placement registration statement to be declared effective within 45-90 calendar days of the initial filing deadline.
  • Hold a stockholder meeting within 60 days of September 25, 2025, to approve the issuance of shares exceeding 19.9% of outstanding shares.
  • File an Initial Registration Statement on Form S-3 for the Equity Purchase Agreement shares by October 25, 2025.
  • Use best efforts to have the Initial Registration Statement (Equity Purchase Agreement) declared effective by November 24, 2025.
  • Commence six equal monthly amortization payments on the Convertible Note starting 180 days after September 25, 2025.
  • Maintain listing of Common Stock on the Principal Market.
  • Comply with all applicable rules and regulations of the SEC and Nasdaq.

Key Dates

DateDescription
2025-09-25Date of earliest event reported; Execution Date of Securities Purchase Agreement and Equity Purchase Agreement.
2025-09-29Date Form 8-K was signed by CFO Lon Ensler.
2025-10-25Deadline for Company to file Initial Registration Statement on Form S-3 for Equity Purchase Agreement shares.
2025-11-24Target date for Initial Registration Statement (Equity Purchase Agreement) to be declared effective by SEC.
2025-12-01If the Company does not send the first Put Notice by this date, the Investor may terminate the Equity Purchase Agreement.
2026-01-25If the Equity Purchase Agreement is terminated on or before this date, 75,000 Pre-Funded Warrant Shares will be cancelled.
2026-01-26If the Equity Purchase Agreement is in effect on this date, all 750,000 Pre-Funded Warrant Shares will be exercisable.
2026-03-25Approximate 6-month anniversary of Original Issue Date of Convertible Note, when amortization payments begin.
2026-09-25Maturity Date of Junior Secured Convertible Note.

Recommendation

hold

The capital raise provides Momentus with much-needed liquidity and a flexible funding mechanism, which is crucial for its operations. However, the terms involve significant potential dilution for existing shareholders and impose restrictive covenants. While the immediate capital infusion is positive, the long-term impact depends on the company's ability to execute its business plan and improve its stock performance to mitigate dilution. The fixed purchase price for the equity line and the conversion price of the note are below recent trading levels, suggesting a cautious outlook on the stock's immediate upside without further operational improvements. Investors should hold and monitor execution and dilution.

Keywords

Momentus Inc., MNTS, SEC Filing, 8-K, Private Placement, Convertible Note, Warrants, Equity Line of Credit, Capital Raise, Dilution, Nasdaq, Securities Purchase Agreement, Yield Point NY LLC, Space Infrastructure

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.